Syngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
SYNGENE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts less than Nifty Smallcap 250 and 3.4 pts less than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Syngene International has received an order dated October 17, 2025 from the Deputy Commissioner of Income-tax in Bengaluru, giving effect to an earlier National Faceless Appeal Centre order for AY 2015-16. The tax demand has been reduced from Rs.79.84 crore to Rs.48.61 crore (including interest), following rectification of apparent mistakes in an earlier 2021 assessment order. The original demand of Rs.37.20 crore raised in December 2017 is still under appeal and proceedings are ongoing. No penalty, restriction, or sanction has been imposed in the current order. The company states it believes it has strong merits in the case and expects no material impact on its financials, operations, or activities, and is analysing the order to decide further action.
The reduced tax demand is a mildly positive development for shareholders, as it cuts the potential outflow by roughly Rs.31 crore. However, the matter remains open and the final outcome of the original 2017 appeal is still pending, so it is unlikely to cause any major swing in the stock price in the near term.